Literature DB >> 24506401

Seric ion level and its relationship with the symptoms of premenstrual syndrome in young women.

Larissa Almenara Silva dos Santos1, Vilma Blondet de Azeredo2, Diane Eloy Chaves Barbosa3, Solange Augusta de Sá4.   

Abstract

UNLABELLED: The aim of the study was to evaluate the seric ions level and its relationship with Premenstrual Syndrome (PMS) symptoms in young women.
METHOD: Ninety-three volunteers were monitored for three months. The nutritional status evaluation was based on BMI. Three "maps of daily symptoms" were used to investigate the frequency of the SPM symptoms. The biochemical evaluation was done in the first month in the luteal phase. The levels of sodium, potassium, calcium, magnesium were determined by colorimetric methods. The hemoglobin and hematocrit concentration were determined by conventional methods.
RESULTS: The symptoms like anxiety (1,13; 0,81; 0,66), edema (0,99; 0,51; e 0,22), depression (0,58; 0,36; 0,20) and mastalgia (0,56; 0,35; 0,09) were the most evident in the menstrual than luteal and follicular phase. A small number of volunteers presented hypocalemia (1,4%), hyponatremia (4,22%) and hypernatremia (7,04%). However, the higher number of the volunteers presented lower calcium level (83,09%). The frequency of anemic women was high (24%). Significant associations (P < 0.05) were observed between the anxiety symptom and sodium (r = 0,2630); and magnesium and depression (r = 0,2508) and nauseas (r = 2882).
CONCLUSIONS: The anemia and hypocalcemia is a important nutritional problem. The regulation of the calcium serum level seems to be affected in the luteal phase of the menstrual cycle and the sodium and magnesium ions influence some psychological (anxiety and depression) and gastrointestinal (nausea and constipation) symptoms. Copyright AULA MEDICA EDICIONES 2013. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24506401     DOI: 10.3305/nutr hosp.v28in06.6648

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  1 in total

1.  Paeoniflorin, the Main Active Ingredient of Shuyu Capsule, Inhibits Cav1.2 and Regulates Calmodulin/Calmodulin-Dependent Protein Kinase II Signalling.

Authors:  Chunhong Song; Jieqiong Wang; Dongmei Gao; Yanhong Yu; Fang Li; Sheng Wei; Peng Sun; Meiyan Wang; Mingqi Qiao
Journal:  Biomed Res Int       Date:  2017-12-06       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.